Linde India Q1 FY26 Results:
Net profit declined 6% to ₹107 crores, compared to ₹114 crores in Q1 FY25. Total income in Q1 FY26 declined 14% to ₹575 crores from ₹672 crores in the same period last year.
About Linde India Ltd
Linde India Ltd. is a prominent industrial gas and engineering company. It has been serving the industry since its inception on January 24, 1935. Formerly known as BOC India Ltd., the company is headquartered in Kolkata, West Bengal. The company’s product portfolio is comprehensive, encompassing industrial gases such as oxygen, nitrogen, and argon. Linde India also supplies medical gases that are crucial for healthcare facilities. Additionally, their expertise extends to the development and construction of air separation facilities, both cryogenic and non-cryogenic. These facilities are essential for industrial gas production. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-3.12%
Over 6 Months
-22.96%
Over 1 Year
-15.86%
Over 3 Years
87.06%
Linde India Ltd Summary
Close ₹5,800
Open ₹5,741
High ₹5,855.50
Low ₹5,741
Volume 18,552
Net Turnover (in Cr) ₹10.77
52Wk High ₹7,870
52Wk Low ₹5,242.40
52Wk High / Low
5,242.40
7,870
Linde India Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹49,462.40
EPS (TTM) 59.33
Book Value (BV) 463.31
Div. Yield 0.21 %
P/E (TTM) 97.83
Price/Book Value 12.53
Delivery % 53.93 %
Face Value 10
Key Ratios
PE Ratio 119.03
PB Ratio 14.11
EV to Sales 21.40
PEG Ratio 23.61
ROA 11.38
ROE 12.42
Debt-Equity 0.01
Net Profit Margin 18.02
Operating Profit Margin 33.51
Linde India Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 2,553.22 | 2,845.68 | 3,239.49 | 2,166.62 | 1,503.76 |
| Total Expenses | 1,946.74 | 2,274.56 | 2,629.84 | 1,749.79 | 1,278.52 |
| Profit Before Tax | 613.50 | 578.87 | 618.29 | 697.90 | 228.66 |
| Profit After Tax | 454.85 | 434.09 | 538.06 | 507.22 | 151.10 |
| Operating Profit After Depreciation | 619.10 | 578.39 | 615.95 | 419.88 | 231.49 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 1,925.20 | 1,821.54 | 1,762.43 | 1,868.55 | 1,989.19 |
| Total Non Current Assets | 4,165.35 | 2,878.13 | 2,350.96 | 2,171.79 | 2,199.95 |
| Total Current Assets | 977.39 | 1,927.11 | 2,048.82 | 1,844.82 | 1,086.14 |
| Total Assets | 5,142.74 | 4,805.24 | 4,399.78 | 4,016.61 | 3,286.09 |
| Total Shareholder's Fund | 3,819.94 | 3,468.43 | 3,140.10 | 2,714.89 | 2,234.31 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 583.60 | 440.40 | 629.18 | 588.88 | 338.96 |
| Net Cash Used In Investing Activities | -1,304.86 | -539.43 | -306.42 | 98.43 | -54.14 |
| Net Cash Used In Financing Activities | -112.18 | -108.76 | -119.45 | -28.16 | -200.72 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 2,553.22 | 2,845.68 | 3,244.26 | 2,166.62 | 1,503.76 |
| Total Expenses | 1,946.74 | 2,274.56 | 2,629.84 | 1,749.79 | 1,278.52 |
| Profit Before Tax | 606.47 | 571.12 | 614.42 | 711.26 | 236.39 |
| Profit After Tax | 447.81 | 426.34 | 535.77 | 513.94 | 155.53 |
| Operating Profit After Depreciation | 619.10 | 578.39 | 620.71 | 419.88 | 231.49 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 1,925.20 | 1,821.54 | 1,762.43 | 1,868.55 | 1,989.19 |
| Total Non Current Assets | 4,132.79 | 2,852.60 | 2,333.18 | 2,157.88 | 2,198.32 |
| Total Current Assets | 977.39 | 1,927.11 | 2,048.82 | 1,844.82 | 1,060.50 |
| Total Assets | 5,110.18 | 4,779.71 | 4,382.01 | 4,002.70 | 3,258.82 |
| Total Shareholder's Fund | 3,779.01 | 3,434.53 | 3,113.95 | 2,691.02 | 2,203.72 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 583.60 | 440.40 | 629.18 | 588.88 | 338.96 |
| Net Cash Used In Investing Activities | -1,304.86 | -539.43 | -306.42 | 98.43 | -54.14 |
| Net Cash Used In Financing Activities | -112.18 | -108.76 | -119.45 | -28.16 | -200.72 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 644.19 | 571.08 | 591.88 | 605.86 | 634.42 |
| Total Expenses | 361.87 | 374.05 | 382.02 | 413.71 | 455.58 |
| Profit Before Tax | 228.27 | 144.34 | 161.28 | 156.99 | 143.39 |
| Profit After Tax | 171 | 107.19 | 118.41 | 116.32 | 106.42 |
| Operating Profit after Depreciation | 287.84 | 203.49 | 223.33 | 213.80 | 197.33 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 644.19 | 571.08 | 591.88 | 605.86 | 634.42 |
| Total Expenses | 361.87 | 374.05 | 382.02 | 413.71 | 455.58 |
| Profit Before Tax | 226.28 | 142.22 | 160.77 | 154.66 | 141.35 |
| Profit After Tax | 169.01 | 105.07 | 117.90 | 113.99 | 104.39 |
| Operating Profit after Depreciation | 285.85 | 201.37 | 222.82 | 211.47 | 195.29 |
Linde India Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 5,742.17
S2 5,684.33
S3 5,627.67
Pivot 5,798.83
R1 5,856.67
R2 5,913.33
R3 5,971.17
Moving Average
20 SMA 5,866.68
50 SMA 6,041.46
100 SMA 6,261.85
200 SMA 6,395.43
Linde India Ltd Corporate Actions
Linde India Ltd
₹7.5/Share
Announcement Date 07 Aug 2025
Record Date 07 Aug 2025
Div Yield 75%
Linde India Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Pidilite Industries Ltd | ₹1,484.70 | ₹1,51,100 |
| SRF Ltd | ₹2,840.70 | ₹84,205.40 |
| Gujarat Fluorochemicals Ltd | ₹3,342.60 | ₹36,718.46 |
| Godrej Industries Ltd | ₹1,008.30 | ₹33,960.03 |
| Navin Fluorine International Ltd | ₹5,763.45 | ₹29,529.91 |
Linde India Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Quant Mid Cap Fund | 3.38% |
| Nippon India Multi Cap Fund | 1.86% |
| Kotak ELSS Tax Saver Fund | 1.86% |
| Kotak Large & Midcap Fund | 1.66% |
| Nippon India ELSS Tax Saver Fund | 1.05% |
Linde India Ltd News
Linde India to announce Quarterly Result
On 6 November 2025
28 Oct 2025, 10:17 am
Linde India commences commercial production of new gas facility in Unnao
15 Sep 2025, 06:18 pm
Linde India to declare Quarterly Results
On 7 August 2025
26 Jul 2025, 09:49 am
Linde India jumps after Q4 PAT rises 12% YoY
Linde India rose 6.57% to Rs 7520 after the company's consolidated net profit rose 12.33% to Rs 118.41 crore while net sales declined 6.06% to Rs 591.88 crore in Q4 March 2025 over Q4 March 2024.
26 May 2025, 01:00 pm
Linde India to convene AGM
On 14 August 2025
24 May 2025, 03:29 pm
Linde India Ltd Stock Analysis
- Annual revenue for Linde India Ltd decreased by 10.28% to ₹2,553.22 crore in FY 2025 from ₹2,845.68 crore in FY 2024.
- Annual Net Profit for Linde India Ltd increased by 5.04% to ₹447.81 crore in FY 2025 from ₹426.34 crore in FY 2024.
- Promoter Shareholding in Linde India Ltd remains unchanged by 0.00% in the most recent quarter, from 75% in June 2025 to 75% in September 2025.
- Linde India Ltd delivered a 1-year return of -15.86% compared to the Nifty 50, which provided a return of 6.40% as of the last trading session.
- Linde India Ltd share price moved down by 0.19% from its previous close of INR ₹5,800. The latest Linde India Ltd share price is INR ₹5,789.
- Linde India Ltd share price today has been at a low of 5,775 and a high of 5,820. Over the past 52 weeks, the Linde India Ltd share price has seen a low of 5,242.40 and a high of 7,870.
About Linde India Ltd
Linde India Ltd. is a prominent industrial gas and engineering company. It has been serving the industry since its inception on January 24, 1935. Formerly known as BOC India Ltd., the company is headquartered in Kolkata, West Bengal.
Linde India Ltd operates as part of the global industrial giant Linde Plc, with BOC Group UK as its promoter (BOC Group Uk owns 75.00% of the total equity).
Under the leadership of Managing Director Abhijit Banerjee and a seasoned management team, including Arun Balakrishnan, Jyotin Mehta and Shalini Sarin, the company has established itself as a key player in the chemicals sector. Their core business revolves around the production and distribution of industrial and medical gases.
The company’s product portfolio is comprehensive, encompassing industrial gases such as oxygen, nitrogen, and argon. These gases cater to various industrial applications. Linde India also supplies medical gases that are crucial for healthcare facilities. Additionally, their expertise extends to the development and construction of air separation facilities, both cryogenic and non-cryogenic. These facilities are essential for industrial gas production.
Linde India maintains a significant presence in the industrial gas sector. However, it’s not a leader in terms of market share or capitalization. The company’s shares are actively traded on both major Indian stock exchanges - the Bombay Stock Exchange (BSE) under ticker 523457 and the National Stock Exchange (NSE) as LINDEINDIA.
Linde India has built a robust foundation in the industrial gases industry. Their association with Linde Plc provides them with access to global expertise and resources. This has helped the company enhance their capabilities in serving diverse industrial sectors. The registered office is near Taratala Road in Kolkata, which serves as the base for their nationwide operations. Meanwhile, their registrars are located in the Financial District of Hyderabad.
Since its establishment in 1935, Linde India has been at the forefront of industrial and medical gas supply. Initially focused on industrial gases, the company soon recognized the growing demand for medical gases. With advancements in healthcare, the need for high-purity medical gases became evident. Linde India responded by developing a robust supply chain. The company also created new production facilities to meet this demand.
Medical oxygen is used for various treatments, like respiratory therapy and life support in intensive care units. Linde India’s production and supply of medical oxygen ensure that healthcare providers can offer these critical treatments effectively. The company adheres to stringent quality control measures to guarantee the purity and safety of its medical gases. This commitment to quality has made Linde India a trusted partner for hospitals and clinics across the country.
The COVID-19 pandemic underscored the importance of medical oxygen as hospitals faced unprecedented demand. Linde India rose to the challenge by ramping up production and ensuring the continuous supply of medical oxygen. The company collaborated with government agencies to set up additional production units. This swift and coordinated response was crucial in saving countless lives.
Linde India’s extensive infrastructure includes multiple air separation units and distribution networks. These facilities have advanced technology to produce, store, and transport medical gases. The company’s investment in technology ensures that it can meet the growing needs of the healthcare sector and maintain the highest standards of safety and reliability.
In addition to supplying medical gases, Linde India provides training and support to healthcare professionals. The company offers educational programs on the safe handling and usage of medical gases. This ensures that hospital staff are well-equipped to manage these critical resources. As a result, Linde India is preventing accidents and ensuring the safe administration of medical treatments.
Linde India is committed to corporate social responsibility. It actively engages with the communities it serves. The company undertakes various initiatives to support healthcare infrastructure and improve medical care. These efforts include donating medical equipment and supporting healthcare projects. Linde India’s focus on community engagement underscores its dedication to improving healthcare outcomes in India.
Linde India aims to continue expanding its capabilities and enhancing its service offerings. The company plans to invest in new technologies and infrastructure to increase its production capacity and ensure a reliable supply of medical gases. It is also planning to stay ahead of industry trends and maintain its commitment to quality. As a result, Linde India is well-positioned to meet the evolving needs of the healthcare sector.
Overall, Linde India’s role in supplying medical gases is critical to the healthcare system in India. The company’s dedication to quality and community engagement has made it a trusted partner for hospitals and healthcare providers. As Linde India continues to expand its capabilities, it will remain a vital player in the medical gas supply chain.
Linde India Ltd operates as part of the global industrial giant Linde Plc, with BOC Group UK as its promoter (BOC Group Uk owns 75.00% of the total equity).
Under the leadership of Managing Director Abhijit Banerjee and a seasoned management team, including Arun Balakrishnan, Jyotin Mehta and Shalini Sarin, the company has established itself as a key player in the chemicals sector. Their core business revolves around the production and distribution of industrial and medical gases.
The company’s product portfolio is comprehensive, encompassing industrial gases such as oxygen, nitrogen, and argon. These gases cater to various industrial applications. Linde India also supplies medical gases that are crucial for healthcare facilities. Additionally, their expertise extends to the development and construction of air separation facilities, both cryogenic and non-cryogenic. These facilities are essential for industrial gas production.
Linde India maintains a significant presence in the industrial gas sector. However, it’s not a leader in terms of market share or capitalization. The company’s shares are actively traded on both major Indian stock exchanges - the Bombay Stock Exchange (BSE) under ticker 523457 and the National Stock Exchange (NSE) as LINDEINDIA.
Linde India has built a robust foundation in the industrial gases industry. Their association with Linde Plc provides them with access to global expertise and resources. This has helped the company enhance their capabilities in serving diverse industrial sectors. The registered office is near Taratala Road in Kolkata, which serves as the base for their nationwide operations. Meanwhile, their registrars are located in the Financial District of Hyderabad.
Linde India’s Critical Role in Medical Gas Supply
Linde India Ltd., a part of the global Linde Plc, plays a crucial role in supplying medical gases in India. The company’s expertise in cryogenic technology and extensive network ensures that hospitals and healthcare facilities receive essential gases like medical oxygen, which is vital for patient care. This critical service has become even more significant during the recent global health crises.Since its establishment in 1935, Linde India has been at the forefront of industrial and medical gas supply. Initially focused on industrial gases, the company soon recognized the growing demand for medical gases. With advancements in healthcare, the need for high-purity medical gases became evident. Linde India responded by developing a robust supply chain. The company also created new production facilities to meet this demand.
Medical oxygen is used for various treatments, like respiratory therapy and life support in intensive care units. Linde India’s production and supply of medical oxygen ensure that healthcare providers can offer these critical treatments effectively. The company adheres to stringent quality control measures to guarantee the purity and safety of its medical gases. This commitment to quality has made Linde India a trusted partner for hospitals and clinics across the country.
The COVID-19 pandemic underscored the importance of medical oxygen as hospitals faced unprecedented demand. Linde India rose to the challenge by ramping up production and ensuring the continuous supply of medical oxygen. The company collaborated with government agencies to set up additional production units. This swift and coordinated response was crucial in saving countless lives.
Linde India’s extensive infrastructure includes multiple air separation units and distribution networks. These facilities have advanced technology to produce, store, and transport medical gases. The company’s investment in technology ensures that it can meet the growing needs of the healthcare sector and maintain the highest standards of safety and reliability.
In addition to supplying medical gases, Linde India provides training and support to healthcare professionals. The company offers educational programs on the safe handling and usage of medical gases. This ensures that hospital staff are well-equipped to manage these critical resources. As a result, Linde India is preventing accidents and ensuring the safe administration of medical treatments.
Linde India is committed to corporate social responsibility. It actively engages with the communities it serves. The company undertakes various initiatives to support healthcare infrastructure and improve medical care. These efforts include donating medical equipment and supporting healthcare projects. Linde India’s focus on community engagement underscores its dedication to improving healthcare outcomes in India.
Linde India aims to continue expanding its capabilities and enhancing its service offerings. The company plans to invest in new technologies and infrastructure to increase its production capacity and ensure a reliable supply of medical gases. It is also planning to stay ahead of industry trends and maintain its commitment to quality. As a result, Linde India is well-positioned to meet the evolving needs of the healthcare sector.
Overall, Linde India’s role in supplying medical gases is critical to the healthcare system in India. The company’s dedication to quality and community engagement has made it a trusted partner for hospitals and healthcare providers. As Linde India continues to expand its capabilities, it will remain a vital player in the medical gas supply chain.
FAQ’s
What is the share price of Linde India Ltd today?
Linde India Ltd share price as on 5 Dec 2025 is ₹ 5789.0
What is the Market Cap of Linde India Ltd?
The market cap of Linde India Ltd stock is ₹49,462.40 Cr.
What is the PE Ratio of Linde India Ltd?
The Price to Earnings (P/E) Ratio of Linde India Ltd is 119.03
What is the PB Ratio of Linde India Ltd?
The Price to Book (P/B) Ratio of Linde India Ltd is 14.11
What is the 52 week high of Linde India Ltd Share Price?
The 52 week high of Linde India Ltd share price stands at ₹7,870
What is the 52 week low of Linde India Ltd Share Price?
The 52 week low of Linde India Ltd share price stands at ₹5,242.40
How can I buy shares of Linde India Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Linde India Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
